用于恶性胶质瘤的放射反应性TRAIL基因治疗 - Suppr | 超能文献

Radio-responsive TRAIL gene therapy for malignant gliomas.

作者信息

Kyritsis A P, Rao J S, Puduvalli V K

出版信息

Cancer Gene Ther. 2007 Dec;14(12):1002. doi: 10.1038/sj.cgt.7701083. Epub 2007 Aug 17.

DOI:10.1038/sj.cgt.7701083

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Radio-responsive TRAIL gene therapy for malignant gliomas.

Cancer Gene Ther. 2007 Dec;14(12):1002. doi: 10.1038/sj.cgt.7701083. Epub 2007 Aug 17.

2

Radioresponsive tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy for malignant brain tumors.

Cancer Gene Ther. 2007 Aug;14(8):706-16. doi: 10.1038/sj.cgt.7701065. Epub 2007 Jun 1.

3

Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.

Cancer Res. 2008 Dec 1;68(23):9614-23. doi: 10.1158/0008-5472.CAN-08-0451.

4

Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.

Neurosurgery. 2009 Sep;65(3):610-24; discussion 624. doi: 10.1227/01.NEU.0000350227.61132.A7.

5

MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.

Cancer Res. 2007 Oct 1;67(19):8994-9000. doi: 10.1158/0008-5472.CAN-07-1045.

6

Radiation-inducible caspase-8 gene therapy for malignant brain tumors.

Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):517-25. doi: 10.1016/j.ijrobp.2008.02.002. Epub 2008 Apr 11.

7

[Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].

Zhonghua Yi Xue Za Zhi. 2009 Mar 31;89(12):841-5.

8

Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration.

Cancer Res. 2006 Dec 15;66(24):11878-87. doi: 10.1158/0008-5472.CAN-06-2354.

9

Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.

Int J Oncol. 2008 Oct;33(4):759-65.

10

Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.

Breast Cancer Res Treat. 2008 Jul;110(2):283-95. doi: 10.1007/s10549-007-9731-4. Epub 2007 Sep 26.

引用本文的文献

1

Cisplatin-enhanced sensitivity of glioblastoma multiforme U251 cells to adenovirus-delivered TRAIL in vitro.

Tumour Biol. 2010 Dec;31(6):613-22. doi: 10.1007/s13277-010-0077-x. Epub 2010 Jul 11.